Logo

Galderma: New Data Reveals Benefits of Combining Oral and Topi...

LAUSANNE, Switzerland, Mar. 1, 2019 /PRNewswire-AsiaNet/-- First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin 1% cream (IVM), versus ivermectin 1% cream plus placebo in adults with severe papulopustular rosacea, reveals mor...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660